Latest Strategy Changes News

Brazilian Rare Earths Limited (ASX – BRE) has announced a maiden JORC-compliant Mineral Resource Estimate for its Amargosa Bauxite-Gallium Project in Bahia, Brazil, revealing a substantial deposit with high-quality bauxite and significant gallium content.

ASIC has initiated civil proceedings against Fiducian’s subsidiary, alleging misleading statements and compliance failures related to a now-closed investment fund. Fiducian is cooperating but remains tight-lipped as the case unfolds.

GoldArc Resources has unveiled strong assay results from its Leonora South drilling program, confirming a robust gold system at Eclipse and Challenge prospects with high-grade, near-surface mineralisation. The company is now targeting a maiden Mineral Resource Estimate and further drilling to expand the resource.

Western Yilgarn Limited has raised $698,000 through a share placement to fund exploration and development at its key bauxite-gallium projects, backed by updated resource estimates confirming substantial alumina deposits.

West Wits Mining Limited has presented a robust update on its flagship Qala Shallows gold project, showcasing a strong Definitive Feasibility Study and secured senior debt funding, targeting first gold production in early 2026.

NexGen Energy has expanded its Australian equity offering to AUD 600 million alongside a concurrent C$400 million North American deal, aiming to accelerate development of its flagship Rook I uranium project.

Cobram Estate Olives has successfully closed a $6.1 million Share Purchase Plan alongside a $2 million shortfall placement, fueling its US growth ambitions. The capital raise complements a recent $175 million institutional placement, underpinning the company’s strategic farmland acquisitions and olive grove developments in America.

Eclipse Metals has commenced mobilisation for its 2025 diamond drilling program at the Grønnedal Rare Earths Carbonatite Complex in Greenland, aiming to expand a significant rare earth mineral resource rich in critical magnet metals.

Invex Therapeutics has ended negotiations on two neurological asset acquisitions following due diligence setbacks and shareholder disputes, while advancing R&D collaborations and managing financial stability.

QuickFee Limited has completed the sale of its US Pay Now business, announced a 7.5 cent per share capital return, appointed founder Bruce Coombes as CEO, and updated its FY26 earnings guidance.

European Lithium Limited is set to repurchase up to 10% of its shares on market, aiming to capitalize on a significant discount to its underlying asset value, particularly its stake in Critical Metals Corp.

The Calmer Co (ASX – CCO) reported an impressive $8 million revenue for FY25, marking 86% year-over-year growth and positioning itself as a global leader in the emerging kava market. With expanding retail presence and strong US sales, the company is on track to break even in 2026.